Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity

Journal of Investigative Dermatology

Volumn 127, Issue 8, 2007, Pages 1956-1963

  Watanabe, Hideki ^a   Gaide, Olivier ^a   Pétrilli, Virginie ^b   Martinon, Fabio ^b,e   Contassot, Emmanuel ^a   Roques, Stéphanie ^a   Kummer, Jean A ^c   Tschopp, Jürg ^b   French, Lars E ^d  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROBENZENE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MULTIPROTEIN COMPLEX; UNCLASSIFIED DRUG; 1 FLUORO 2,4 DINITROBENZENE; CARRIER PROTEIN; CYTOSKELETON PROTEIN; NLRP3 PROTEIN, HUMAN; PICRYL CHLORIDE; PYCARD PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; CONTACT ALLERGY; CONTACT SENSITIZATION; ENZYME ACTIVATION; HUMAN; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; CONTACT DERMATITIS; DRUG EFFECT; INFLAMMATION; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE;

CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; KERATINOCYTES; PICRYL CHLORIDE;

EID: 34250792190     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700819     Document Type: Article

References (42)

1. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319-25
2. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511
3. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW (2001) Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 166:3672-7
4. Ashikaga T, Hoya M, Itagaki H, Katsumura Y, Aiba S (2002) Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 16:711-6
5. Bigby M, Kwan T, Sy MS (1987) Ratio of Langerhans cells to Thy-1+ dendritic epidermal cells in murine epidermis influences the intensity of contact hypersensitivity. J Invest Dermatol 89:495-9
6. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA et al. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97-100
7. Cumberbatch M, Bhushan M, Dearman RJ, Kimber I, Griffiths CE (2003) IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 132:352-9
8. Cumberbatch M, Dearman RJ, Groves RW, Antonopoulos C, Kimber I (2002) Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol 182:126-35
9. Dajee M, Muchamuel T, Schryver B, Oo A, Alleman-Sposeto J, De Vry CG et al. (2006) Blockade of experimental atopic dermatitis via topical NF-kappa B decoy oligonucleotide. J Invest Dermatol 126:1792-803
10. Dinarello CA (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 856:1-11
11. Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 150:3698-704
12. Faria AM, Weiner HL (2005) Oral tolerance. Immunol Rev 206:232-59
13. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A et al. (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-23
14. Grabbe S, Schwarz T (1998) Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37-44
15. Grabbe S, Steinert M, Mahnke K, Schwartz A, Luger TA, Schwarz T (1996) Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific pro-inflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. J Clin Invest 98:1158-64
16. Griffiths CE, Dearman RJ, Cumberbatch M, Kimber I (2005) Cytokines and langerhans cell mobilisation in mouse and man. Cytokine 32:67-70
17. Hawkins PN, Lachmann HJ, McDermott MF (2003) Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 348:2583-4
18. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I et al. (1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 13:6231-40
19. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL et al. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779-85
20. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L et al. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440:233-6
21. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005) Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-20
22. Kawase Y, Hoshino T, Yokota K, Kuzuhara A, Kirii Y, Nishiwaki E et al. (2003) Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin. J Invest Dermatol 121:502-9
23. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T (1997) Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 159:2484-91
24. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-32
25. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417-26
26. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-41
27. Martinon F, Tschopp J (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-74
28. Martinon F, Tschopp J (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26:447-54
29. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-5
30. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991) Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821-5
31. Murphy JE, Robert C, Kupper TS (2000) Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 114:602-8
32. Naik SM, Cannon G, Burbach GJ, Singh SR, Swerlick RA, Wilcox JN et al. (1999) Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with proinflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 113:766-72
33. Pirrone A, Hager B, Fleckman P (2005) Primary mouse keratinocyte culture. In: Epidermal Cells: Methods and Protocols. (K. Turksen ed). Humana Press Inc: Totowa, 3-14
34. Riemann H, Loser K, Beissert S, Fujita M, Schwarz A, Schwarz T et al. (2005) IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen. J Immunol 175: 5866-74
35. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D et al. (2003) TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124:1001-9
36. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-21
37. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW et al. (1996) Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 183:1427-36
38. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES (2002) The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277:21119-22
39. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317-27
40. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-74
41. Wang B, Feliciani C, Howell BG, Freed I, Cai Q, Watanabe H et al. (2002) Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J Immunol 168:3303-8
42. Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H et al. (2000) Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165:997-1003